NCT06097468 2026-04-13
Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
University of California, San Francisco
Phase 1/2 Recruiting
Clinical Trials
11 trialsNCT07512921 2026-04-06
BIOMATCH
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT06532279 2026-04-03
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NRG Oncology
Phase 2 Recruiting
NCT05681039 2026-03-02
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05031910 2026-02-17
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
Thomas Jefferson University
Phase NA Recruiting
NCT06995508 2026-02-17
Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial
Roswell Park Cancer Institute
Phase 2 Recruiting
NCT04694846 2025-09-09
Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use
Thomas Jefferson University
Phase NA Completed
NCT06367257 2025-04-10
App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
University of Erlangen-Nürnberg Medical School
Phase NA Recruiting
NCT05707702 2024-05-01
Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia
Boston Medical Center
Phase 3 Withdrawn
NCT05412875 2024-04-12
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT03088059 2023-11-03
UPSTREAM
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Unknown